30
Participants
Start Date
April 1, 2021
Primary Completion Date
December 31, 2023
Study Completion Date
March 1, 2025
Mepolizumab 100 MG
Discovery of predictive/prognostic biomarkers of response to mepolizumab using flow cytometry, transcriptomic, and proteomic technologies.
NOT_YET_RECRUITING
Complexo Hospitalario Universitario A Coruña, A Coruña
RECRUITING
Complejo Hospitalario Universitario de Ferrol, Ferrol
NOT_YET_RECRUITING
Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela
RECRUITING
Complexo Hospitalario Universitario de Ourense, Ourense
NOT_YET_RECRUITING
Hospital Povisa - Grupo Ribera Salud, Vigo
Collaborators (1)
Hospital Clinico Universitario de Santiago
OTHER
GlaxoSmithKline
INDUSTRY